Skip to main content

Table 2 Clinical characteristics of the patients in the events investigated.

From: Ventilator associated pneumonia: comparison between quantitative and qualitative cultures of tracheal aspirates

Parameter Total evaluations (%) Evaluations in VAP group (%)
Number of evaluations 219 (100%) 38 (100%)
Tracheostomy (n [%]) 59 (26.9%) 10 (26.3%)
Atelectasisa (n [%]) 13 (6.0%) 6 (15.7%)
Lung edemaa (n [%]) 35 (16.0%) 9 (23.6%)
Lung contusiona (n [%]) 6 (2.7%) 1 (2.6%)
Pleural effusiona (n [%]) 21 (9,5%) 8 (21.0%)
Previous lung disease (n [%]) 30 (13.6%) 6 (15.7%)
COPD 16 (7.3%) 3 (7.8%)
Cancer 11 (5.0%) 2 (5.2%)
Asthma 2 (0.9%) 1 (2.6%)
Pulmonary fibrosis 1 (0.4%) None
Broncoaspiration (n [%]) 12 (5.4%) 3 (7.8%)
Sepsis (n [%]) 46 (21.0%) 14 (36.8%)
ARDS (n [%]) 12 (5,4%) 3 (7.8%)
Renal failure (n [%]; creatinine >2.0 mg/dl) 91 (41.5%) 20 (52.6%)
Diabetes (n [%]) 35 (16.0%) 5 (13.1%)
Chemotherapy (n [%]) 13 (6.0%) 2 (5.2%)
Radiotherapy (n [%]) 2 (0.9%) None
Immunossupressants drugs (n [%]) 5 (2.2%) 1 (2.6%)
AIDS (n [%]) 3 (1.3%) None
Renal transplantation (n [%]) 5 (2.2%) 1 (2.6%)
Abdominal surgery (n [%]) 32 (14.6%) 7 (18.4%)
Multiple trauma (n [%]) 21 (9.5%) 3 (7.9%)
Neuromuscular blocking agents (n [%]) 7 (3.1%) 7 (18.4%)
Central venous line (n [%]) 215 (98.0%) 38 (100%)
Intracranial pressure monitoring (n [%]) 20 (9.1%) 1 (2.6%)
  1. aAccording to clinical judgement. ARDS, acute respiratory distress syndrome; COPD, chronic obstructive pulmonary disease; VAP, ventilator-associated pneumonia.